Bill

Bill > A5383


NJ A5383

NJ A5383
Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.


summary

Introduced
03/06/2025
In Committee
12/08/2025
Crossed Over
06/30/2025
Passed
Dead
01/12/2026

Introduced Session

2024-2025 Regular Session

Bill Summary

Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

AI Summary

This bill requires New Jersey Medicaid to provide coverage for ovulation-enhancing drugs and related medical services for individuals experiencing infertility, specifically for people aged 21 to 44 years old. The coverage is limited to three treatment cycles per lifetime and includes specific medical services such as office visits, hysterosalpingograms (a type of X-ray to examine the fallopian tubes), pelvic ultrasounds, and blood testing. The bill defines infertility based on the inability to establish a clinical pregnancy after 12 months of regular, unprotected sexual intercourse for individuals 21-34 years old, and after six months for individuals 35-44 years old. Importantly, the definition cannot be used to deny or delay treatment based on an individual's relationship status or sexual orientation. The bill also requires the Commissioner of Human Services to apply for necessary federal approvals and plan amendments to implement these new Medicaid benefits and secure federal financial participation. The coverage will take effect on the first day of the fourth month following the bill's enactment.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (7)

Last Action

Referred to Senate Budget and Appropriations Committee (on 12/08/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...